Targeted gene delivery capitalizes on the presence of specific cell surface receptors for DNA uptake into cells by receptormediated endocytosis (1-3). Therefore, receptor binding ligands are coupled to polycationic compounds like polylysine (pL) 1 that bind and condense DNA. Following this concept, transferrin polylysine (TfpL)-based gene transfer systems were developed to target transferrin receptor for DNA delivery into cells (1, 4 -7). Binding of TfpL/DNA complexes to transferrin receptor causes internalization and DNA uptake into the endosomal compartment (8). To facilitate DNA release from this compartment, endosomolytic agents (such as inactivated adenoviruses) were included in transfection complexes and were demonstrated to effectively enhance gene transfer efficiency (8 -10). More recently, transferrin polyethylenimine (TfPEI) conjugates have been synthesized and used for DNA delivery, thereby combining the high intrinsic transfection efficacy of polyethylenimine (PEI) with receptor-targeted gene transfer (11, 12) . PEI possesses DNA binding and condensing activity together with a high pH buffering capacity that is believed to protect DNA from degradation and to enhance exit from the endosomal compartment. Accordingly, PEI is effective in gene delivery into a variety of cell types even without the addition of cell binding ligands or endosomolytic agents (13, 14). Here we investigated whether the mannose receptor that is abundantly expressed on dendritic cells (DC) represents a suitable entry site for targeted gene delivery into DC using mannosylated PEI (ManPEI).
Targeted gene delivery capitalizes on the presence of specific cell surface receptors for DNA uptake into cells by receptormediated endocytosis (1) (2) (3) . Therefore, receptor binding ligands are coupled to polycationic compounds like polylysine (pL) 1 that bind and condense DNA. Following this concept, transferrin polylysine (TfpL)-based gene transfer systems were developed to target transferrin receptor for DNA delivery into cells (1, 4 -7) . Binding of TfpL/DNA complexes to transferrin receptor causes internalization and DNA uptake into the endosomal compartment (8) . To facilitate DNA release from this compartment, endosomolytic agents (such as inactivated adenoviruses) were included in transfection complexes and were demonstrated to effectively enhance gene transfer efficiency (8 -10) . More recently, transferrin polyethylenimine (TfPEI) conjugates have been synthesized and used for DNA delivery, thereby combining the high intrinsic transfection efficacy of polyethylenimine (PEI) with receptor-targeted gene transfer (11, 12) . PEI possesses DNA binding and condensing activity together with a high pH buffering capacity that is believed to protect DNA from degradation and to enhance exit from the endosomal compartment. Accordingly, PEI is effective in gene delivery into a variety of cell types even without the addition of cell binding ligands or endosomolytic agents (13, 14) . Here we investigated whether the mannose receptor that is abundantly expressed on dendritic cells (DC) represents a suitable entry site for targeted gene delivery into DC using mannosylated PEI (ManPEI).
DC are professional antigen-presenting cells that occur in peripheral organs like skin, where these cells are exposed to antigens, which they capture and process (15) (16) (17) (18) . Upon inflammatory stimuli, DC migrate to lymphoid tissue and present processed antigens on major histocompatibility complex (MHC) class I and II molecules to T cells, to elicit an antigenspecific T cell response. Because of their central role in the initiation of primary immune responses, there is high interest in employing DC for immunotherapy of diseases, such as cancer (19 -21) . Following such approaches, gene-modified DC offer several potential advantages over peptide/protein-pulsed DC. For example, gene-modified DC can be expected to induce T cell responses against multiple and/or undefined epitopes of tumor antigens, possibly in the context of both MHC class I and II, and with any MHC allele. Furthermore, the expression of chemokines and cytokines in DC simultaneously with tumorspecific and/or associated antigens would additionally allow modulation of the immune response. DC and T cell functions are effectively regulated by a variety of cytokines, and local cytokine production by DC might represent an important adjunct for T cell activation in medical therapy, for example in cancer patients who are often immunosuppressed. However, so far the generation of gene-modified immunocompetent DC has remained difficult mainly due to limitations in DNA delivery techniques (12, 21, 22) .
DC express high levels of mannose receptor and mannose receptor-related receptor that are used for endocytosis and phagocytosis of a variety of antigens that expose mannose and fucose residues (16, (23) (24) (25) (26) . DC also express transferrin receptor, albeit at lower levels. 2 Following ligand binding, internalization, and release of cargo, both mannose and transferrin receptor are recycled and transported back to the cell surface, where they allow repeated internalization of new ligand molecules (1, 4, 27) . For this reason, mannose receptor might be similar to transferrin receptor and particularly suited for tar-geted delivery of DNA into cells by employing synthetic mannose polycation conjugates and using a strategy that was successfully applied before for transferrin receptor. Here we describe the synthesis of ManPEI conjugates and have investigated uptake of ManPEI/DNA transfection complexes and their efficacy in DNA delivery. Based on previous successful enhancement of receptor-mediated gene delivery by endosomolytic agents, ManPEI/DNA complexes containing endosomedisrupting adenovirus particles were also generated and investigated.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture-Human DC were generated from peripheral blood monocytes by treatment with granulocyte-macrophage colonystimulating factor (GM-CSF) and interleukin-4 (IL-4) as described (28, 29) . Peripheral blood mononuclear cells were isolated from buffy coat preparations of healthy donors by Ficoll Hypaque centrifugation (density of 1.077 g/cm 3 ; Eurobio, Paris, France) followed by T cell depletion with aminoethylthiouronium bromide (Sigma)-treated sheep red blood cells. The T cell-depleted cell fraction was then depleted of B cells and residual T cells using anti-CD19 and anti-CD2 ferromagnetic beads (Dynabeads M-450 Pan-B (CD19) and Pan-T (CD2); Dynal). The cells obtained were cultured in RPMI 1640 medium (Life Technologies, Inc.) containing 10% inactivated fetal calf serum (Life Technologies, Inc.), 2 mM glutamine, 100 units/ml penicillin and streptomycin in the presence of GM-CSF (500 units/ml; kindly provided by Novartis) and IL-4 (500 units/ml; kindly provided by Schering-Plough) at 37°C in 5% CO 2 atmosphere for 6 -10 days.
Mouse DC were prepared from bone marrow (30) . Briefly, bone marrow cells were obtained from hind legs of female C57BL/6 mice and seeded on tissue culture dishes to remove strongly adherent cells. After 1 h, nonadherent cells were recovered and transferred into a new dish. Cultures were grown in RPMI 1640 medium containing 10% inactivated fetal calf serum, 50 M ␤-mercaptoethanol, 100 units/ml penicillin and streptomycin, and 300 units/ml mouse GM-CSF. At days 1 and 3, nonadherent cells were removed, and adherent cells were further cultured. At day 7, nonadherent and loosely adherent DC were harvested and used for transfection experiments.
Human macrophages were prepared from peripheral blood monocytes essentially as described for human DC (see above) but incubated in culture medium without cytokines for 2-10 days. B cells were obtained by immunomagnetic bead purification (see above) and cultured for 2 days to facilitate the release of beads.
BM2 chicken myeloblasts (31) were grown in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 8% fetal calf serum (Life Technologies, Inc.), 2% chicken serum (Sigma), 10 mM HEPES, and 100 units/ml penicillin and streptomycin.
Plasmid Vectors and Adenovirus-The following reporter constructs were used: pCluc plasmid (32) encoding the Photinus pyralis luciferase gene and pEGFP-C1 (CLONTECH Laboratories) bearing a mutated variant of green fluorescent protein (GFP); pcDNA3-␤-gal containing ␤-galactosidase cDNA in pcDNA-3 vector (Invitrogen); and pcDNA3-OVA encoding the chicken ovalbumin gene prepared by cloning the EcoRI/XbaI fragment of pGEM-OVA (33) into pcDNA-3. In all constructs, expression of the respective reporter gene is under control of the cytomegalovirus immediate early enhancer/promoter. Plasmid DNA was prepared by alkaline lysis followed by Triton-X114 purification to remove lipopolysaccharide (34) .
Active wild type adenovirus type 5 (wtAd) and active or psoraleninactivated E4-defective Ad5 strain dl1014 (E4 Ϫ Ad; Ref. 35 ) was used (36, 37) . Virus growth, purification, biotinylation of E4 Ϫ Ad, and inactivation with psoralen were performed as described previously (38) . The viral stocks were quantified by protein content (1 mg/ml protein ϭ 3.4 ϫ 10 12 viral particles/ml; Ref. 39) .
Synthesis of ManPEI
Conjugates-ManPEI conjugates were synthesized similarly as described for mannose polylysine conjugates (40) . Man-itc-PEI conjugate had mannose linked to PEI via a phenylisothiocyanate bridge using mannopyranosylphenyl isothiocyanate (Sigma) as coupling reagent. PEI was purified by gel filtration in 250 mM NaCl and subsequent dialysis against water. Coupling was performed by reacting 25 mg of PEI in 0.33 ml of water with 25 mg of mannopyranosylphenyl isothiocyanate in 0.2 ml of dimethyl sulfoxide for at least 1 day, followed by dilution with 4 ml of water and adjustment to 0.5 M sodium chloride, cation exchange chromatography (Bio-Rad Macroprep High S, salt gradient from 0.5 to 3 M sodium chloride) and dialysis against 150 mM sodium chloride. Conjugates were analyzed for content of PEI and mannose, by using ninhydrin assay (41) and a resorcinol sulfuric acid method (42), respectively. Man-itc-PEI 25 and Man-itc-PEI 800 consisted of 25-kDa low molecular mass PEI or 800-kDa high molecular mass PEI (Aldrich) containing mannopyranosylphenyl isothiocyanate/PEI at a 1:1.4 and 1:1.3 weight ratio, respectively. This represents an average modification of every tenth (25 kDa) or ninth (800 kDa) PEI nitrogen with mannose. Man-bio-PEI conjugate was obtained by reductive amination with mannobiose in an analogous fashion as for the lactosylation described in Ref. 32 . Reaction of 25 mg of PEI (800 kDa) in 0.5 ml of 250 mM aqueous sodium chloride with 25 mg of mannobiose (Sigma) and reduction with three portions of sodium cyanoborohydride (2 mg, at 1-h intervals), followed by dilution, cationic exchange chromatography, and dialysis (as described above), resulted in a conjugate that contained 800-kDa high molecular mass PEI at a mannobiose/PEI weight ratio of 1:2.
ManPEI Transfection-ManPEI transfection complexes were generated by mixing 4 g of plasmid DNA in 300 l of HEPES-buffered saline (150 mM NaCl, 20 mM HEPES, pH 7.4) with various amounts of Man-PEI conjugate in 300 l of HEPES-buffered saline followed by incubation at room temperature (20 min). For formation of Ad/ManPEI/DNA complexes, an increasing amount of adenovirus particles (see above) was added, and samples were incubated for an additional 20 min. 300 l of this transfection solution were given to 5 ϫ 10 5 cells in 500 l of serum-free culture medium in 24-well plates; all transfections were done in duplicates. Transfection medium was replaced by complete culture medium after 4 h. Reporter gene assays were performed at day 1-2 after transfection.
In ManPEI transfection/blocking experiments, cells were preincubated with various amounts of mannosylated bovine serum albumin (ManBSA, Sigma) in 500 l of serum-free culture medium for 30 min. Then 300 l of ManPEI transfection complex was added, and transfection was performed as described above. As control, cells were preincubated with an equivalent amount of unconjugated bovine serum albumin (BSA; Sigma), transfected, and processed accordingly.
Reporter Gene Assays-For luciferase assays, cells were washed once with phosphate-buffered saline and lysed by three cycles of "freeze and thaw" in 0.25 M Tris buffer, pH 7.5 (43) . Luciferase activity of lysate was measured in a Lumat LB9501 (Berthold, Wildbad, Germany) and normalized for protein content. All values represent means of duplicates or of multiple measurements with the S.D. values indicated. GFP expression was detected by fluorescence microscopy (Axiophot, Zeiss) or by flow cytometry using a FACScalibur devise (Beckton Dickinson) and employing propidium iodide (PI) staining for gating on viable cells (see below).
Flow Cytometry-Surface antigen expression of DC was analyzed by flow cytometry. To block unspecific binding, cells were incubated first in staining buffer (phosphate-buffered saline plus 1% BSA, fraction V, Sigma; 30 min, 4°C) containing 1% human IgG for human DC (Beriglobin; Behringwerke, Marburg, Germany) and then reacted with unconjugated or fluorescein isothiocyanate (FITC)-labeled mouse monoclonal antibodies (1 h, 4°C). Samples containing unlabeled antibodies were stained with FITC-conjugated goat anti-mouse antibody (Sigma; 45 min, 4°C). Cells were washed three times, resuspended in staining buffer and PI (2 g/ml, Sigma) for gating on viable cells, and analyzed by flow cytometry using a FACScalibur device with CELLQuest software (Becton Dickinson). The antibodies used were as follows: MHC class I (HLA-A, -B, -C, clone G46 -2. Mannose receptor expression was determined by incubating cells with 1 mg/ml FITC-labeled mannosylated BSA (FITC-ManBSA; Sigma) for 1 h at 37°C in the presence of 10 mM sodium fluoride to prevent receptor internalization (26) . Control cells were processed similarly but incubated at 4°C; under these conditions, no binding of ManBSA to receptor is found. Cells were then washed twice and resuspended in staining buffer followed by flow cytometry as above. PI (2 g/ml) was used for gating on viable cells. To block binding of FITC-ManBSA to mannose receptor, cells were preincubated for 20 min with various amounts of unlabeled ManBSA or as a control with unconjugated BSA; FITC-ManBSA was added, and samples were processed as described above.
Cell viability was determined by PI staining of nonviable cells and flow cytometry (see above). The proportion of viable cells was determined with viability of untreated cells set at 100%.
Ovalbumin (OVA)-specific T Cell Activation-Splenocytes of OT-I mice (44, 45) were prepared, and CD8 ϩ T cells were obtained by immunomagnetic bead purification using MACS anti-CD8 Microbeads (Miltenyi Biotec). These T cells express a transgenic T cell receptor that recognizes OVA-(257-264) peptide on H-2K b and were cocultured with irradiated mouse DC (5000 rads) in 96-well microtiter plates. Transfected DC were used at day 1 after transfection; untreated DC and DC pulsed with 0.5 M OVA-(257-264) peptide (SIINFEKL) were employed as controls. Further controls were T cells stimulated by phorbol 12-myristate 13-acetate (25 ng/ml; Sigma) and ionomycin (1 g/ml; Sigma). After 1 day, culture supernatant was harvested and tested by enzymelinked immunosorbent assay for interleukin-2 (IL-2) production (R&D Systems (28, 29) . The cell populations obtained routinely contained 96 -98% DC as determined by cell surface marker expression and flow cytometry and were used for transfection at day 7-9 of culture. Mouse DC were obtained from bone marrow cells cultured with GM-CSF for 7 days (30) and used for transfection. By that time, both human and mouse DC exhibited the typical morphology of DC and expressed high levels of MHC class I and class II and of the costimulatory molecules B7.1 and B7.2 (data not shown). Cells were highly active in stimulating T cell proliferation in allogenic mixed leukocyte reactions. As expected, both human DC and macrophages expressed mannose receptor from day 2 to 10 in culture as determined by staining with anti-mannose receptor-specific antibody (Fig. 1A) , while the starting cell population was negative (data not shown). In addition, mannose receptor expression on DC was consistently found to be higher than on macrophages. Mannose receptor levels were also detected by binding of FITC-ManBSA, yielding the same result (Fig. 1B) . Human B cells were negative. Interestingly, mouse bone marrow-derived DC showed considerably lower mannose receptor levels than human DC yet were competent in taking up transfection complexes via mannose receptor (see below).
To investigate the efficacy of gene delivery into DC via mannose receptor, several ManPEI conjugates were synthesized. Man-itc-PEI conjugate has a phenylisothiocyanate bridge for linking the mannose moiety to PEI, while Man-bio-PEI consists of the disaccharide mannobiose linked to PEI (Fig. 1C) . Conjugates contained either low or high molecular weight PEI (25-and 800-kDa PEI, in the following referred to as PEI 25 and PEI 800 , respectively). To generate ManPEI/DNA transfection complexes harboring a luciferase reporter gene, ManPEI conjugate and plasmid DNA were mixed, and complexes were transfected into DC. Cells were analyzed for luciferase activity 1-2 days later. To determine whether incorporation of adenovirus in transfection complexes would increase gene delivery, Ad/ManPEI/DNA transfection complexes were also generated (Fig. 1C) . Briefly, ManPEI conjugate and luciferase plasmid DNA were mixed to form ManPEI/DNA complexes, followed by the addition of adenovirus particles that bind to PEI by charged interactions with negative domains on the viral hexon.
For initial studies, we used the BM2 myeloblast cell line that expresses moderate mannose receptor levels (see below) and that can be grown as homogenous cell population to large cell numbers. In these experiments, a conjugate/DNA ratio of 1:1 was found to be optimal, yielding 0.6 -1.6 ϫ 10 8 light units/mg of protein for both Man-itc-PEI and Man-bio-PEI conjugate ( Fig. 2A) . Unconjugated PEI was about 500 -1000-fold less efficient than either ManPEI conjugate.
To investigate a potential cytotoxic effect of the ManPEI conjugates used, the proportion of viable cells following transfection was determined by PI staining and flow cytometry. For BM2 cells, viability decreased with increasing amounts of Man-PEI in transfection complexes in a dose-dependent fashion and was at the optimal 1:1 conjugate/DNA ratio, 60.5, 46.7, and 44.5% for Man-itc-PEI, Man-bio-PEI, and unmodified PEI, re- spectively (Fig. 2B) . Interestingly, ManPEI transfection affected the viability of human DC to a lesser extent (86.7, 60.1, and 75.8% for Man-itc-PEI, Man-bio-PEI, and unmodified PEI, respectively). Thus, Man-itc-PEI and Man-bio-PEI behaved very similarly, and Man-itc-PEI conjugate was chosen for further transfection experiments (in the following referred to as ManPEI), since it only marginally affected cell viability.
Next, the influence of low and high molecular mass PEI (25-and 800-kDa PEI, respectively) on transfection efficiency of ManPEI conjugates was investigated. Again, a conjugate/DNA ratio of 1:1 was found to be optimal, resulting in BM2 cells in about 10 8 light units/mg of protein for both ManPEI 25 and ManPEI 800 ( Fig. 3A and data not shown). As expected, unconjugated PEI was less effective than ManPEI. To further extend these results, ManPEI transfection was applied to human DC that were obtained from peripheral blood mononuclear cells by in vitro differentiation in the presence of GM-CSF and IL-4. Fig. 3B shows that ManPEI 25 and ManPEI 800 conjugates were equally efficient in delivery of a luciferase reporter gene into DC, with ManPEI being more potent than unconjugated PEI. Essentially the same result was obtained with bone marrowderived mouse DC (data not shown). In addition, as expected for transfection of primary cells, the luciferase values obtained were lower than those measured for the BM2 cell line.
Uptake of ManPEI/DNA transfection complexes was clearly receptor-specific. BM2 cells express moderate levels of mannose receptor as demonstrated by binding of FITC-labeled ManBSA and analysis by flow cytometry (Fig. 4A) . Furthermore, the addition of unlabeled ManBSA effectively reduced binding of FITC-labeled ManBSA to BM2 cells, while unconjugated BSA did not. Most importantly, ManBSA severely reduced luciferase expression in ManPEI transfection experiments in a dose-dependent fashion (Fig. 4B) , indicating that ManBSA blocks uptake of ManPEI/DNA transfection complexes by binding to the limited number of mannose receptor molecules present on the cell surface.
Adenovirus Particles Enhance Gene Expression by ManPEI
Transfection-Previous studies demonstrated that adenovirus can effectively enhance receptor-mediated gene delivery in several systems due to its potent endosomolytic activity (4, 8 -10 ).
Therefore, adenoviral particles were incorporated in ManPEI transfection complexes to determine if this would increase the efficacy of ManPEI transfection. Ad/ManPEI/DNA complexes (Fig. 1C) were generated using wtAd and E4 Ϫ Ad and analyzed in transfection experiments. To test for contribution of viral gene expression to transgene expression, active and psoraleninactivated E4 Ϫ Ad were employed. We demonstrate that in primary mouse and human DC, the addition of wtAd dramatically enhances luciferase expression by 1000-and 10,000-fold, respectively, while in BM2 cells the effect was only moderate (10-fold; Fig. 5 ). E4
Ϫ Ad was only slightly less efficient than wtAd in both DC and BM2 cells. However, psoralen inactivation of E4
Ϫ Ad clearly compromised adenovirus-augmented luciferase expression in DC, while the decline with psoralen-
FIG. 3. ManPEI transfection of BM2 cells and human DC. A,
ManPEI/DNA and PEI/DNA transfection complexes containing low or high molecular weight PEI (25 or 800 kDa, respectively) and the luciferase reporter gene were generated and transfected into BM2 cells. The conjugate/DNA ratio was 1:1 (w/w). ManPEI 25 and ManPEI 800 containing a phenylisothiocyanate linker (Man-itc-PEI) were used, and cells were analyzed for luciferase activity at day 2 after transfection. B, human DC were transfected with ManPEI/DNA and PEI/DNA complexes as in A and analyzed for luciferase activity at day 1 after transfection. S.D. values of three independent experiments are shown.
FIG. 2. ManPEI transfection of Man-bio-PEI and Man-itc-PEI conjugates.
A, ManPEI/DNA and PEI/DNA transfection complexes containing 800-kDa PEI and the luciferase reporter gene were transfected into BM2 cells. To determine optimal transfection efficiencies, various conjugate/DNA ratios were analyzed as indicated (1:10, 1:2, 1:1, 2:1, and 10:1 (w/w)). For PEI/DNA, the optimal polycation/DNA ratio of 1:1 (w/w) is shown. Luciferase activity was determined at day 2 after transfection. The activity of Man-itc-PEI and Man-bio-PEI conjugates containing a phenylisothiocyanate and mannopyranosyl linker, respectively, is depicted. To determine whether adenovirus-augmented ManPEI transfection was receptor-specific, blocking experiments with ManBSA were performed. An increasing number of adenovirus particles in Ad/ManPEI/DNA transfection complexes enhanced luciferase expression in human DC, while this effect was less pronounced in BM2 cells (Fig. 6, A and B) . ManBSA effectively competed with Ad/ManPEI/DNA complex binding to mannose receptor and, at low adenovirus particle numbers, reduced luciferase activity by 3-and 100-fold in DC and BM2 cells, respectively. Interestingly, Ad/ManPEI/DNA transfection complexes containing higher numbers of adenovirus particles showed a less severe reduction or no reduction in transgene expression in response to ManBSA. This finding indicates that under these conditions uptake of Ad/ManPEI/DNA complexes predominantly occurs by mechanisms independent of mannose receptor, possible via the adenovirus internalization route. Unconjugated BSA, used as control, left luciferase activity unaffected irrespective of the number of adenovirus particles per transfection complex (data not shown).
Finally, to determine the proportion of transgene-expressing cells, ManPEI/DNA transfection complexes containing GFP expression plasmid were generated. BM2 cells were transfected by employing the same transfection conditions as for luciferase vector and then analyzed for GFP expression by flow cytometry. ManPEI 25 and ManPEI 800 conjugate yielded 2.8 and 1.3% GFP-positive cells, respectively, and the proportion of GFPpositive cells was further increased by the presence of adenovirus particles in transfection complexes (12.8 and 4%, respectively; Table I ). ManPEI 800 conjugate containing mannobiose behaved in a very similar manner to the respective ManPEI conjugate containing a isothiocyanate linker (Table I) . Increasing the number of adenovirus particles per complex was associated with elevated cytotoxicity and therefore did not augment transgene expression (data not shown).
OVA-specific T Cell Activation Induced by Ad/ManPEItransfected Mouse DC-We next determined whether ManPEItransfected DC are competent in inducing antigen-specific T cell responses. Therefore, mouse DC were transfected with an OVA-encoding expression plasmid using ManPEI or Ad/Man-PEI transfection complexes. At day 1 after transfection, DC were irradiated and cocultured with CD8 ϩ T cells of OT-I mice, which express a transgenic T cell receptor specific for OVA-(257-264) peptide presented by MHC class I H-2K b . IL-2 production was determined at day 1 of coculture, and T cell proliferation was measured at day 5. It was found that Ad/ ManPEI/OVA-transfected DC initiate an antigen-specific T cell response as evidenced by stimulation of IL-2 production and T cell proliferation (Fig. 7, A and B) . ManPEI transfection of OVA cDNA without adenovirus particles did not induce T cell activation, which is probably due to low antigen expression level (see above). As expected, ␤-galactosidase-transfected DC were inactive, as were untreated DC, while peptide-pulsed DC were highly active.
DISCUSSION
Here we describe the synthesis of ManPEI conjugates and their analysis for receptor-targeted gene delivery. ManPEI transfection represents a fully synthetic delivery system that capitalizes on gene transfer by receptor-mediated endocytosis via surface-bound mannose receptor that is highly expressed on antigen-presenting DC. By employing ManPEI rather than mannosylated polylysine conjugates, we took advantage of the higher transfection potential of conjugated PEI as observed for transferrin conjugates (TfPEI versus TfpL) in various cell types (11) and also in initial TfPEI transfection studies in DC (12) . Mannosylated polylysine conjugates were employed in related studies for targeting mannose receptor in macrophages (40, 46) . Several ManPEI conjugates were synthesized by reductive amination with mannobiose or by coupling with mannosylphenylisothiocyanate to generate Man-bio-PEI and Man-itc-PEI conjugates, respectively. Both conjugates were found to exhibit similar physical properties and transfection potential when tested in mannose receptor-positive BM2 myeloblasts. The influence of low and high molecular mass PEI (25-and 800-kDa PEI, respectively) on ManPEI/DNA transfection was also studied. Again, ManPEI 25 and ManPEI 800 conjugates showed similar transfection efficiencies. Additionally, blocking experiments demonstrated that the uptake of ManPEI/DNA transfection complexes was mannose receptor-specific.
While these studies demonstrated that ManPEI conjugates are effective in gene delivery via mannose receptor, their transfection potential for primary human and mouse DC was found to be rather low. This appears not to be due to differences in mannose receptor levels, which were the same for BM2 cells and mouse DC and even higher in human DC. Importantly, incorporation of adenovirus particles in ManPEI transfection complex dramatically increased transgene expression as observed for both wild type Ad particles as well as replicationdeficient E4
Ϫ Ad particles. This might be due to the fact that, following uptake of such Ad/ManPEI/DNA complexes via mannose receptor, the adenovirus component facilitates DNA release from the endosomal compartment, similar to its action in adenovirus-augmented transferrinfection (4, 8 -10) . Alternatively adenovirus itself might contribute to uptake of Ad/Man-PEI/DNA complexes via the adenovirus infection route. Such an idea would be in line with the finding that Ad/PEI/DNA transfection complexes containing plasmid DNA bound to adenovirus carrier via PEI (36, 37, 47) are effective in delivering genes into DC (48) . Furthermore, Ad/ManPEI/DNA transfection complexes containing a high number of adenovirus particles were found to be less affected by blocking the mannose receptor internalization route with ManBSA than complexes not containing adenovirus particles. Thus, Ad/ManPEI/DNA complexes apparently bind to cells and deliver DNA at least in part via the adenovirus moiety of the complex.
It appears therefore that in DC uptake of DNA via the adenovirus internalization route is more effective than via mannose receptor, while for BM2 cells both routes are equally efficient. In DC, the difference between both uptake pathways might be the extent of endosomal degradation that could be particularly high for mannose receptor-targeted complexes. We have attempted to address this question by applying agents that increase the endosomal pH and thereby inhibit lysosomal degradation like chloroquin and monensin (6, 7, 49) . However, so far these studies have met with only limited success due to the high unspecific cytotoxicity of the compounds used.
Finally, our study demonstrates that ManPEI/DNA complexes containing adenovirus particles are effective in activating T cells from T cell receptor transgenic mice in an antigenspecific manner. DC transfected with ManPEI/DNA complexes Ϫ adenovirus (E4 Ϫ Ad* and E4 Ϫ Ad, respectively) or wtAd was used. Transfection of ManPEI/DNA complexes without adenovirus is shown as control. Man-itc-PEI containing 800-kDa PEI was employed; conjugate/DNA ratio was 1:1 (w/w). Luciferase activity at day 2 after transfection is shown. Human (B) and mouse (C) DC were transfected with Ad/ManPEI/DNA (3000 adenovirus particles/cell) complexes and ManPEI/DNA (control) containing the luciferase reporter gene as in A and analyzed for luciferase activity at day 1 after transfection. Ϫ adenovirus particles/cell) were transfected into BM2 cells without preincubation (gray bars) or after preincubation with 1 mg of ManBSA (black bars) to block mannose receptor-mediated DNA uptake. Luciferase activity was determined at day 2 after transfection. B, Ad/ManPEI transfection of luciferase gene into human DC as in A. Luciferase activity was determined at day 1 after transfection.
TABLE I GFP expression following ManPEI transfection
ManPEI/DNA transfection complexes containing Man-itc-PEI or Man-bio-PEI and 25-or 800-kDa PEI, as indicated, and GFP expression plasmid were transfected into BM2 cells. Transfection complexes contained 0 or 1000 psoralen-inactivated E4
Ϫ adenovirus particles/cell (Ϫ Ad and ϩ Ad, respectively). 2 days after transfection, cells were analyzed for GFP expression by flow cytometry. The proportion of GFPpositive cells is given in percentage of total cell number with S.D. as indicated. As a control, PEI/DNA complexes with 25-or 800-kDa PEI with the optimal polycation/DNA ratio of 1:1 (w/w) are shown. without adenovirus particles were deficient in inducing such a T cell response, which is presumably related to low transgene expression, and higher expression levels might be required to overcome this limitation. Current experiments aim at incorporating synthetic endosome-disruptive influenza peptides (50) in ManPEI transfection complexes to address this question. Such a system would have the advantage of being fully synthetic. The present study opens the possibility to use ManPEI transfection for gene delivery into DC to study DC function and to develop DC-based approaches of immunotherapy, e.g. of cancer or viral or infectious diseases. Other transfection techniques so far tested for DC were mostly inefficient and associated with high unspecific cytotoxicity and low transgene expression (12, 22) . Additionally, DC from peripheral blood monocytes, as used in this study, are largely postmitotic and difficult to infect with recombinant retroviruses that rely on proliferating cells (51, 52) . More recently recombinant adenovirus vectors were applied for transduction of DC (12, 22, 53, 54) . The ManPEI transfection system described in this paper is particularly versatile and offers several advantages over viral vectors. For example, very large DNA constructs (more than 100 kilobase pairs) can be transfected to ensure long lasting transgene expression (36) . More importantly, several plasmid DNAs can be transfected simultaneously to induce and/or modulate immune responses. Current experiments address the question of whether such a modulation of the immune response with genemodified DC can be achieved by coexpression of the antigen with specific cytokines and chemokines that activate or attract T cells. 
